These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22183212)

  • 21. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
    Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression.
    Erices R; Cubillos S; Aravena R; Santoro F; Marquez M; Orellana R; Ramírez C; González P; Fuenzalida P; Bravo ML; Oliva B; Kato S; Ibañez C; Brañes J; Bravo E; Alonso C; García K; Arab C; Torres VA; Godoy AS; Pereira J; Bustos G; Cardenas JC; Cuello MA; Owen GI
    Oncotarget; 2017 Mar; 8(13):20865-20880. PubMed ID: 28209916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
    Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
    Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
    Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
    Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
    Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
    Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.
    Wynn A; Vacheron A; Zuber J; Solomon SS
    Am J Med Sci; 2019 Sep; 358(3):200-203. PubMed ID: 31324361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
    Deng Y; Wang J; Li W; Xiong W; Wang X
    J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
    Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
    BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
    Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
    Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
    Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
    BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
    Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
    Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin.
    Patel T; Hruby G; Badani K; Abate-Shen C; McKiernan JM
    Urology; 2010 Nov; 76(5):1240-4. PubMed ID: 20627287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes.
    Hagberg KW; McGlynn KA; Sahasrabuddhe VV; Jick S
    Br J Cancer; 2014 Oct; 111(9):1710-7. PubMed ID: 25093492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.
    Yin M; Zhou J; Gorak EJ; Quddus F
    Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
    Wink KC; Belderbos JS; Dieleman EM; Rossi M; Rasch CR; Damhuis RA; Houben RM; Troost EG
    Radiother Oncol; 2016 Mar; 118(3):453-9. PubMed ID: 26861738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada.
    Kaur P; Berchuck A; Chase A; Grout B; Deurloo CM; Pearce LC; Pike MC; Richardson J; Terry KL; Webb PM; Hanley GE
    Neoplasia; 2024 Oct; 56():101026. PubMed ID: 38972207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.